Novo Nordisk participates in USD 57m financing round at strategic partner
![Photo: Tidsvilde Stine/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13749852.ece/ALTERNATES/schema-16_9/20160929-062240-pf-1920x1080we%2520(2).jpg)
A partner of Danish pharmaceutical firm Novo Nordisk, US-based Beta Bionics, has been on a successful capital hunt, bringing in USD 57m in a series C financing round, the company informs in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma enters US partnership over pump system
For subscribers
Novo Nordisk sues Teva over generic drug development
For subscribers